Eu Yan Sang to be delisted in October
Add BT as a preferred source
TRADITIONAL Chinese medicine retailer Eu Yan Sang will request a suspension of trading in its shares starting Sept 28 and delist on Oct 7, it said in a Singapore Exchange (SGX) filing on Tuesday.
The delisting spells an end to the group's 16 years on the SGX main board.
It comes after a consortium led by a UOB-backed fund, a Temasek Holdings unit and Eu Yan Sang International's group chief executive officer Richard Eu made a privatisation bid for the company, offering S$0.60 cash for each share that it does not own.
The final closing date for the offer was Sept 27. Eu Yan Sang shares closed a cent higher at S$0.60 on Tuesday.
Share with us your feedback on BT's products and services
TRENDING NOW
Xi Jinping has just rewritten the rules of US-China rivalry
High Court raps UOB over inconsistent legal positions on late mortgage payment charges
‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next
China’s Huawei reveals chip design breakthrough amid US sanctions
